Karl F. Jensen

1.3k total citations
35 papers, 944 citations indexed

About

Karl F. Jensen is a scholar working on Small Animals, Immunology and Developmental Neuroscience. According to data from OpenAlex, Karl F. Jensen has authored 35 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Small Animals, 11 papers in Immunology and 9 papers in Developmental Neuroscience. Recurrent topics in Karl F. Jensen's work include Immunotoxicology and immune responses (11 papers), Animal testing and alternatives (11 papers) and Anesthesia and Neurotoxicity Research (7 papers). Karl F. Jensen is often cited by papers focused on Immunotoxicology and immune responses (11 papers), Animal testing and alternatives (11 papers) and Anesthesia and Neurotoxicity Research (7 papers). Karl F. Jensen collaborates with scholars based in United States, United Kingdom and Japan. Karl F. Jensen's co-authors include Brad Bolon, Robert H. Garman, Robert L. Isaacson, Mark T. Butt, Joseph Altman, G. Krinke, Lisa Schweizer, Raelyn Janssen, Alys Bradley and Ingrid D. Pardo and has published in prestigious journals such as The Journal of Comparative Neurology, Brain Research and Environmental Health Perspectives.

In The Last Decade

Karl F. Jensen

32 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl F. Jensen United States 17 300 210 199 198 156 35 944
William S. Redfern United Kingdom 19 344 1.1× 68 0.3× 62 0.3× 142 0.7× 399 2.6× 35 1.1k
Takayuki Negishi Japan 18 186 0.6× 23 0.1× 63 0.3× 48 0.2× 233 1.5× 55 1.0k
Minhan Ka South Korea 21 165 0.6× 84 0.4× 53 0.3× 18 0.1× 588 3.8× 43 1.1k
J P O'Callaghan United States 17 372 1.2× 37 0.2× 35 0.2× 40 0.2× 360 2.3× 25 991
Attila Zsarnovszky Hungary 15 113 0.4× 55 0.3× 28 0.1× 19 0.1× 194 1.2× 41 918
Gabriela G. Cezar United States 10 105 0.3× 82 0.4× 24 0.1× 35 0.2× 608 3.9× 12 946
Margit Henry Germany 20 414 1.4× 92 0.4× 18 0.1× 34 0.2× 621 4.0× 31 955
Robert A. Durham United States 17 373 1.2× 53 0.3× 81 0.4× 61 0.3× 772 4.9× 22 1.8k
Makiko Kuwagata Japan 15 97 0.3× 52 0.2× 14 0.1× 42 0.2× 176 1.1× 51 674
Xia Chi China 18 114 0.4× 110 0.5× 53 0.3× 9 0.0× 462 3.0× 75 1.1k

Countries citing papers authored by Karl F. Jensen

Since Specialization
Citations

This map shows the geographic impact of Karl F. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl F. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl F. Jensen more than expected).

Fields of papers citing papers by Karl F. Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl F. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl F. Jensen. The network helps show where Karl F. Jensen may publish in the future.

Co-authorship network of co-authors of Karl F. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Karl F. Jensen. A scholar is included among the top collaborators of Karl F. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl F. Jensen. Karl F. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mack, Cina M., Karl F. Jensen, Prasada Rao S. Kodavanti, et al.. (2024). Identification of neural-relevant toxcast high-throughput assay intended gene targets: Applicability to neurotoxicity and neurotoxicant putative molecular initiating events. NeuroToxicology. 103. 256–265. 1 indexed citations
2.
Bolon, Brad, Karyn Colman, Sabine Francke, et al.. (2020). Opinion on Current Use of Non-Blinded Versus Blinded Histopathologic Evaluation in Animal Toxicity Studies. Toxicologic Pathology. 48(4). 549–559. 3 indexed citations
3.
Bolon, Brad, Alys Bradley, Mark T. Butt, Karl F. Jensen, & Deepa B. Rao. (2019). International Regulatory Guiding Documents and Best Practice Recommendations on Peripheral Nervous System (PNS) Histopathologic Evaluation in Good Laboratory Practice (GLP)-Compliant Animal Toxicity Studies. Toxicologic Pathology. 48(1). 78–86. 9 indexed citations
5.
Cowden, John, Beth Padnos, Deborah L. Hunter, et al.. (2012). Developmental exposure to valproate and ethanol alters locomotor activity and retino-tectal projection area in zebrafish embryos. Reproductive Toxicology. 33(2). 165–173. 50 indexed citations
6.
Fan, Chun‐Yang, Steven O. Simmons, Karl F. Jensen, et al.. (2011). Generation and characterization of neurogenin1-GFP transgenic medaka with potential for rapid developmental neurotoxicity screening. Aquatic Toxicology. 105(1-2). 127–135. 5 indexed citations
7.
Bolon, Brad, Alys Bradley, Mark T. Butt, et al.. (2010). Compilation of International Regulatory Guidance Documents for Neuropathology Assessment During Nonclinical General Toxicity and Specialized Neurotoxicity Studies. Toxicologic Pathology. 39(1). 92–96. 26 indexed citations
8.
Bolon, Brad, Robert H. Garman, Hans Jørgen G. Gundersen, et al.. (2010). Continuing Education Course #3. Toxicologic Pathology. 39(1). 289–293. 17 indexed citations
9.
Jensen, Karl F., et al.. (2003). lmmunohistological Markers of Cerebrovascular Integrity. Humana Press eBooks. 22. 271–288.
10.
Jensen, Karl F., et al.. (2003). Selective Silver Staining for Neural Degeneration. Humana Press eBooks. 22. 257–270.
11.
Gupta, Ram P., Ali Abdel‐Rahman, Karl F. Jensen, & Mohamed B. Abou‐Donia. (2000). Altered expression of neurofilament subunits in diisopropyl phosphorofluoridate-treated hen spinal cord and their presence in axonal aggregations. Brain Research. 878(1-2). 32–47. 17 indexed citations
12.
Isaacson, Robert L., et al.. (1997). Toxin‐Induced Blood Vessel Inclusions Caused by the Chronic Administration of Aluminum and Sodium Fluoride and Their Implications for Dementiaa. Annals of the New York Academy of Sciences. 825(1). 152–166. 18 indexed citations
13.
Isaacson, Robert L. & Karl F. Jensen. (1994). Toxins in air and water. Plenum Press eBooks. 9 indexed citations
14.
Jensen, Karl F., et al.. (1994). Long‐range interactions between DNA‐bound ligands. Journal of Molecular Recognition. 7(3). 233–241. 12 indexed citations
15.
Isaacson, Robert L. & Karl F. Jensen. (1992). Malnutrition and hazard assessment. Plenum Press eBooks. 23 indexed citations
16.
Jensen, Karl F., et al.. (1991). Neonatal exposure to trimethyltin disrupts spatial delayed alternation learning in preweanling rats. Neurotoxicology and Teratology. 13(5). 525–530. 28 indexed citations
17.
Janssen, Raelyn, Lisa Schweizer, & Karl F. Jensen. (1991). Glutamate neurotoxicity in the developing rat cochlea: physiological and morphological approaches. Brain Research. 552(2). 255–264. 45 indexed citations
18.
Schweizer, Lisa, Karl F. Jensen, & Raelyn Janssen. (1991). Glutamate neurotoxicity in rat auditory system: Cochlear nuclear complex. Neurotoxicology and Teratology. 13(2). 189–193. 8 indexed citations
19.
Haykal-Coates, Najwa, James P. O’Callaghan, John F. Reinhard, & Karl F. Jensen. (1991). Pargyline and γ-butyrolactone enhance tyrosine hydroxylase immunostaining of nigrostriatal axons. Brain Research. 556(2). 353–357. 9 indexed citations
20.
Jensen, Karl F., et al.. (1971). Alcoholism and Teetotalism in Blood Relatives of Abstaining Alcoholics. Quarterly Journal of Studies on Alcohol. 32(1). 183–185. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026